Integrase inhibitors are particularly beneficial for individuals who are newly diagnosed with HIV, as well as those who have developed resistance to other classes of antiretrovirals. Studies have shown that these drugs are effective across various subpopulations, including different age groups, genders, and ethnicities. They are also suitable for individuals with co-infections such as hepatitis B and C.
